B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization
about
FOXD3 regulates migration properties and Rnd3 expression in melanoma cellsThe Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin CancerAngiogenin enhances cell migration by regulating stress fiber assembly and focal adhesion dynamicsPathophysiological Functions of Rnd3/RhoERaf kinases in cancer-roles and therapeutic opportunitiesRnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensionsThe RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain.B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cellsFunction and regulation of Rnd proteins in cortical projection neuron migrationA switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition.BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.Targeting mutant BRAF in melanoma: current status and future development of combination therapy strategiesThe c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.The GTPase-deficient Rnd proteins are stabilized by their effectors.Melanoma-expressed CD70 is involved in invasion and metastasis.Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction BreakdownMIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma.Oncogenic BRAF-Mediated Melanoma Cell Invasion.Gab2-mediated signaling promotes melanoma metastasis.Epidermal growth factor receptor-PI3K signaling controls cofilin activity to facilitate herpes simplex virus 1 entry into neuronal cells.Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin.Targeting MAPK pathway in melanoma therapy.Plasma membrane--cortical cytoskeleton interactions: a cell biology approach with biophysical considerations.Rho-kinase: regulation, (dys)function, and inhibition.Emerging BRAF inhibitors for melanoma.Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.Role of key genetic mutations on increasing migration of brain cancer cells through confinement.ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells.Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma.Resistance of tumor cells to cytolytic T lymphocytes involves Rho-GTPases and focal adhesion kinase activation.Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification.Overcoming resistance to BRAF inhibitors.
P2860
Q24633339-3312AACA-BFC1-4C65-B85F-BEDAEDA2CF1AQ26747247-95F38345-8339-462C-A2AF-D2BCC690FADEQ27311234-6AB074DD-F220-4F33-A0FA-34BD1CCFB13EQ28078292-BF88C7D7-406F-4242-B91A-FCE9CBD47C37Q28237793-66113AA6-A1B4-4072-9246-59E7765CC1E6Q30486572-8F4C7733-442C-4702-807D-CBFD1BA0C8A2Q33682232-AF59A903-726B-45C5-A300-0D8ECD2C0C23Q34044770-3C6A49D1-7511-4DF0-94F9-5BF7A7DBC20AQ35056615-4F49F446-B6BB-4757-A63A-2CA7998DF672Q35233178-2DE25AB1-64D7-4A3D-B1E4-8F4B961E83B1Q35299011-09A12B90-A26A-4FA6-A5ED-E53D90561DB2Q35643909-69D3323B-7561-4871-ACE2-5D177D90AA8AQ35859282-FED82AFA-F2A0-4ACF-8D33-ACE9545712AEQ36020990-973B4BC8-4BDB-4CEB-BF03-55F1A76082AEQ36234368-345B7A73-0914-418F-9EA6-DB345A783797Q36472971-FCB941AA-6C2F-45F2-85D8-8C3665CE3EABQ36518235-0677C23A-88D7-4B51-B364-A2EFEC892E83Q36682132-B5BDBF9C-FDC7-4C8C-8139-324103CD6967Q36957578-34D5C2DB-B159-4032-A66C-149AA4AC75DCQ37164581-EE88E61E-CABB-42DF-BD03-49A87E82FF99Q37519854-E4A364AC-8211-4961-9E4B-83AB5EE36FF5Q37662318-12EBE80E-D214-4988-ABE1-40E4083BE70DQ38098888-52736843-81E4-4F06-83B3-CFEB7FD16455Q38125148-6C4DA09C-EA03-4A3C-9FA7-3E25FC4A7B5FQ38129373-5BAF14CB-362A-485F-AA48-C6A277FD331EQ38145387-041F3DC8-C039-4C11-A24C-3E080C4EF74CQ38286193-BE988C77-0BE4-4320-8B9D-687BDA6563C9Q38723005-A72BBDF6-2DBD-40E2-89CB-2F6F3B3F8DC0Q38758057-D6ABE55A-BD9E-4ABC-B1C3-D7D30F56ED80Q39215892-B005FE9B-1F40-4171-9DE4-95121113E3AEQ39233170-BFA5D40E-0A14-4C31-95DD-37B45930D442Q39941899-46A2F3A6-1E39-4DB3-9676-56EF72E0B7D3Q42434602-F476C3BA-A6C7-46E1-8E5F-C43C04C7B7D4Q43298157-73330981-B0C4-4E45-8D88-13FD536355A0
P2860
B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@ast
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@en
type
label
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@ast
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@en
prefLabel
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@ast
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@en
P2093
P2860
P356
P1476
B-RAF regulation of Rnd3 parti ...... nd focal adhesion organization
@en
P2093
Andrew E Aplin
Arisa Ortiz
Ethan V Abel
Laurie S Spofford
R Matthew Klein
P2860
P304
P356
10.1091/MBC.E07-09-0895
P577
2007-11-28T00:00:00Z